Open access · CC-BY
via OpenAlex
Senescent cell heterogeneity: The impact of targeting senescent endothelial cells in obesity
Masayoshi Suda, Tamar Tchkonia, James L. Kirkland
Geromedicine · 2026
Abstract
Cellular senescence(definition) is increasingly recognized as a key contributor to many age-related disorders and diseases, and senotherapeutics, therapies that target senescent cells (SCs), have indicated benefits in multiple preclinical models, including models of obesity, metabolic syndrome/diabetes, and their complications. Importantly, SCs are not a uniform population. They differ by originating cell type, stimuli by which senescence was induced, time since induction of senescence, and the tissue and microenvironment in which senescent cells are located, including the composition and magnitude of the senescence-associated secretory phenotype (SASP). Recent studies have indicated that senescent cell populations comprise cells that release inflammatory SASP factors and less inflammatory senescent cells that release growth factors. Senolytics(definition), agents that eliminate senescent cells, preferentially remove the more inflammatory senescent cells while sparing the less inflammatory senescent cells that arise during processes such as acute wound healing. In another study, senescent cell heterogeneity was investigated in adipose tissue impacted by obesity, with a focus on senescence marker expression and cell-type specificity. p16+ senescent endothelial cells were a key source of SASP factors within adipose tissue, but p21+ senescent preadipocytes and immune cells also contributed substantially to the inflammatory milieu. Identifying and selectively targeting the more pathogenic, pro-inflammatory senescent cell populations may be facilitated by single-cell-level analyses to elucidate the extent of senescent cell heterogeneity and markers of different senescent cell subpopulations. Appreciating the diversity of senescent cells may be critical, since refining senotherapies based on specific SC subtypes may lead to the development of individualized and personalized therapies, potentially improving upon existing broader-spectrum strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.70401/geromedicine.2026.0036
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Suda, M., Tchkonia, T., & Kirkland, J.L. (2026). Senescent cell heterogeneity: The impact of targeting senescent endothelial cells in obesity. <em>Geromedicine</em>. https://doi.org/10.70401/geromedicine.2026.0036
Vancouver
Suda M, Tchkonia T, Kirkland JL. Senescent cell heterogeneity: The impact of targeting senescent endothelial cells in obesity. Geromedicine. 2026. doi:10.70401/geromedicine.2026.0036.
BibTeX
@article{masayoshi2026Senesc,
title = {Senescent cell heterogeneity: The impact of targeting senescent endothelial cells in obesity},
author = {Masayoshi Suda and Tamar Tchkonia and James L. Kirkland},
journal = {Geromedicine},
year = {2026},
doi = {10.70401/geromedicine.2026.0036},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Veterinary Pathology 2020
Citation only
Cellular Senescence: Mechanisms, Morphology, and Mouse Models
Cells 2021
Open access · CC-BY
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
Journal of the European Academy of Dermatology and Venereology 2024
Open access · OA
Looking for the philosopher's stone: Emerging approaches to target the hallmarks of aging in the skin
The Journal of Biochemistry 2024
Open access · OA
Targeting senescent cells for the treatment of age-associated diseases
Journal of Internal Medicine 2025
Open access · OA
Senotherapeutics for metabolic disease and diabetic complications
Genes & Development 2015
Preprint · CC-BY